When introduced in the early and middle 1990s, current first-line pharmacologic therapies for multiple sclerosis (MS)-interferon beta-1a, interferon beta-1b, and glatiramer acetate-constituted a major ...
November 11, 2008 (New Orleans, Louisiana) — A phase 2 trial has shown that interferon beta-1b (IFNB-1b) (Betaferon/Betaseron, Bayer Healthcare)--a drug currently used to treat multiple sclerosis (MS) ...
Alemtuzumab improved clinical and magnetic resonance imagining outcomes in patients with relapsing-remitting multiple sclerosis across varying age groups and maintained efficacy through year 8 of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results